Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JZP269 in Healthy Participants
NCT07813663Phase 1Recruiting
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Sep 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in narcolepsy comparing JZP269 with Placebo (2 arms). Primary endpoints: Treatment-emergent Adverse Events, Maximum Concentration and 5 more. Started Sep 2026; status: recruiting.
02
Drugs
JZP269
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT07813663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07813663.